nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comprehensive patient assessment and physician reminder tool for adult immunization: Effect on vaccine administration
|
Fishbein, Daniel B. |
|
2006 |
24 |
18 |
p. 3971-3983 13 p. |
artikel |
2 |
Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis
|
Oliveira-Freitas, E. |
|
2006 |
24 |
18 |
p. 3909-3920 12 p. |
artikel |
3 |
A mutant of Escherichia coli enterotoxin inducing a specific Thl-type of T cells to varicella-zoster vaccine enhances the production of IL-12 by IFNγ-stimulated macrophages
|
Shimizu, Toshiyasu |
|
2006 |
24 |
18 |
p. 3719-3726 8 p. |
artikel |
4 |
A new intranasal influenza vaccine based on a novel polycationic lipid—ceramide carbamoyl-spermine (CCS)
|
Joseph, Aviva |
|
2006 |
24 |
18 |
p. 3990-4006 17 p. |
artikel |
5 |
An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits
|
Wimer-Mackin, S. |
|
2006 |
24 |
18 |
p. 3953-3963 11 p. |
artikel |
6 |
A randomised controlled study of the reactogenicity of an acellular pertussis-containing pentavalent infant vaccine compared to a quadrivalent whole cell pertussis-containing vaccine and oral poliomyelitis vaccine, when given concurrently with meningococcal group C conjugate vaccine to healthy UK infants at 2, 3 and 4 months of age
|
Kitchin, Nicholas |
|
2006 |
24 |
18 |
p. 3964-3970 7 p. |
artikel |
7 |
A short report on clinical evaluation of RIX4414: highlights of world-wide development
|
Vos, B. De |
|
2006 |
24 |
18 |
p. 3777-3778 2 p. |
artikel |
8 |
A short report on highlights of world-wide development of RIX4414: A Latin American experience
|
Linhares, A.C. |
|
2006 |
24 |
18 |
p. 3784-3785 2 p. |
artikel |
9 |
A short report on highlights of world-wide development of RIX4414: An European experience
|
Vesikari, T. |
|
2006 |
24 |
18 |
p. 3779- 1 p. |
artikel |
10 |
A short report on highlights of worldwide development of RIX4414: A Singaporean experience
|
Phua, K.B. |
|
2006 |
24 |
18 |
p. 3782-3783 2 p. |
artikel |
11 |
A short report on the highlights of world-wide development of RIX4414: a North American experience
|
Dennehy, Penelope H. |
|
2006 |
24 |
18 |
p. 3780-3781 2 p. |
artikel |
12 |
Biosafety evaluation of recombinant live oral bacterial vaccines in the context of European regulation
|
Favre, Didier |
|
2006 |
24 |
18 |
p. 3856-3864 9 p. |
artikel |
13 |
Catecholate receptor proteins in Salmonella enterica: role in virulence and implications for vaccine development
|
Williams, P.H. |
|
2006 |
24 |
18 |
p. 3840-3844 5 p. |
artikel |
14 |
Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers
|
Carpenter, C.M. |
|
2006 |
24 |
18 |
p. 3709-3718 10 p. |
artikel |
15 |
Construction and evaluation of a O139 Vibrio cholerae vaccine candidate based on a hemA gene mutation
|
Ravichandran, Manickam |
|
2006 |
24 |
18 |
p. 3750-3761 12 p. |
artikel |
16 |
Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli
|
Zhu, Chengru |
|
2006 |
24 |
18 |
p. 3821-3831 11 p. |
artikel |
17 |
DNA vaccines against enteric infections
|
Herrmann, John E. |
|
2006 |
24 |
18 |
p. 3705-3708 4 p. |
artikel |
18 |
DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses
|
Borrego, Belen |
|
2006 |
24 |
18 |
p. 3889-3899 11 p. |
artikel |
19 |
Editorial Board
|
|
|
2006 |
24 |
18 |
p. CO2- 1 p. |
artikel |
20 |
Enteric infections and the vaccines to counter them: Future directions
|
Levine, Myron M. |
|
2006 |
24 |
18 |
p. 3865-3873 9 p. |
artikel |
21 |
Establishment of a non-human primate Campylobacter disease model for the pre-clinical evaluation of Campylobacter vaccine formulations
|
Islam, Dilara |
|
2006 |
24 |
18 |
p. 3762-3771 10 p. |
artikel |
22 |
Human immune response towards recombinant Helicobacter pylori urease and cellular fractions
|
Voland, Petra |
|
2006 |
24 |
18 |
p. 3832-3839 8 p. |
artikel |
23 |
Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations
|
Ramasamy, R. |
|
2006 |
24 |
18 |
p. 3900-3908 9 p. |
artikel |
24 |
Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model
|
Barry, Eileen M. |
|
2006 |
24 |
18 |
p. 3727-3734 8 p. |
artikel |
25 |
Interchangeability of two diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate vaccines as a fourth dose in 15–20-month-old toddlers
|
Halperin, Scott A. |
|
2006 |
24 |
18 |
p. 4017-4023 7 p. |
artikel |
26 |
Intussusception and rotavirus vaccines
|
Bines, Julie |
|
2006 |
24 |
18 |
p. 3772-3776 5 p. |
artikel |
27 |
Late vaccination reinforcement during a measles epidemic in Niamey, Niger (2003–2004)
|
Dubray, Christine |
|
2006 |
24 |
18 |
p. 3984-3989 6 p. |
artikel |
28 |
Live, attenuated Salmonella typhimurium vectoring Campylobacter antigens
|
Sizemore, Donata R. |
|
2006 |
24 |
18 |
p. 3793-3803 11 p. |
artikel |
29 |
Local immune responses following nasal delivery of an adjuvanted influenza vaccine
|
Scheerlinck, Jean-Pierre Y. |
|
2006 |
24 |
18 |
p. 3929-3936 8 p. |
artikel |
30 |
Nonviral therapeutic cell vaccine mediates potent antitumor effects
|
Moret-Tatay, Inés |
|
2006 |
24 |
18 |
p. 3937-3945 9 p. |
artikel |
31 |
Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638
|
Talavera, A. |
|
2006 |
24 |
18 |
p. 3746-3749 4 p. |
artikel |
32 |
Quantifying influenza vaccine efficacy and antigenic distance
|
Gupta, Vishal |
|
2006 |
24 |
18 |
p. 3881-3888 8 p. |
artikel |
33 |
Quantitative evaluation of genetic and environmental parameters determining antibody response induced by vaccination against bovine respiratory syncytial virus
|
O’Neill, R.G. |
|
2006 |
24 |
18 |
p. 4007-4016 10 p. |
artikel |
34 |
Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial
|
McKenzie, R. |
|
2006 |
24 |
18 |
p. 3735-3745 11 p. |
artikel |
35 |
Safety of influenza vaccinations administered in nontraditional settings
|
D’Heilly, Sarah J. |
|
2006 |
24 |
18 |
p. 4024-4027 4 p. |
artikel |
36 |
Survival of neutralizing antibody in previously rabies vaccinated subjects: A prospective study showing long lasting immunity
|
Suwansrinon, K. |
|
2006 |
24 |
18 |
p. 3878-3880 3 p. |
artikel |
37 |
The epidemiology of varicella and herpes zoster in The Netherlands: Implications for varicella zoster virus vaccination
|
de Melker, Hester |
|
2006 |
24 |
18 |
p. 3946-3952 7 p. |
artikel |
38 |
The jejunal Peyer's patches are the major inductive sites of the F4-specific immune response following intestinal immunisation of pigs with F4 (K88) fimbriae
|
Snoeck, V. |
|
2006 |
24 |
18 |
p. 3812-3820 9 p. |
artikel |
39 |
The MMR vaccination and autism controversy in United Kingdom 1998–2005: Inevitable community outrage or a failure of risk communication?
|
Burgess, David C. |
|
2006 |
24 |
18 |
p. 3921-3928 8 p. |
artikel |
40 |
The New World primate, Aotus nancymae, as a model for examining the immunogenicity of a prototype enterotoxigenic Escherichia coli subunit vaccine
|
Jones, Franca R. |
|
2006 |
24 |
18 |
p. 3786-3792 7 p. |
artikel |
41 |
Towards a vaccine for attaching/effacing Escherichia coli: a LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strain
|
Zhu, Chengru |
|
2006 |
24 |
18 |
p. 3845-3855 11 p. |
artikel |
42 |
Vaccines against typhoid fever
|
Guzman, Carlos A. |
|
2006 |
24 |
18 |
p. 3804-3811 8 p. |
artikel |
43 |
WHO discussion on the improvement of the quality control of BCG vaccines
|
Knezevic, I. |
|
2006 |
24 |
18 |
p. 3874-3877 4 p. |
artikel |